Abbott (ABT) Tops Q4 EPS by 2c, Updates FY Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/25/2026
- Wall St ends mixed as tech megacap declines outweigh upbeat chip outlook
- Micron posts record profit as AI memory demand fuels explosive growth
- Brent settles at lowest since before start of Iran war as more tankers exit Hormuz
- IBM surges on unveiling sub-1nm chip technology breakthrough
- 'Long-term deals significant positive for stock:' Analysts react to Micron results
- Two major earthquakes strike Venezuela, killing at least 32 and injuring hundreds
- Needham Starts NeoVolta (NEOV) at Buy
- Rockstar Games opens GTA VI pre-orders, priced at $79.99
- Rubio meets Gulf leaders, pledges security amid Iran deal doubts
- Hertz cuts guidance, announces notes and stock offerings, shares sink
Abbott Labs (ABT) PT Raised to $72 at Cowen
July 19, 2018 8:23 AM EDTCowen raised its price target on Abbott Labs (NYSE: ABT) to $72.00 (from $68.00) while maintaining a Outperform rating following solid Q2 results.
Analyst Joshua Jennings notes organic growth was 8%, versus 6%-7% guidance range and also north of the 7% organic rate shown in 1Q. Also, guidance was raised despite a strong dollar.
... MoreAbbott Labs (ABT) PT Raised to $70 at RBC Capital
July 19, 2018 7:16 AM EDTRBC Capital raised its price target on Abbott Labs (NYSE: ABT) to $70.00 (from $67.00) while maintaining a Outperform rating.
Analyst Glenn Novarro said results again demonstrated powerful momentum across all four segments, especially outside the U.S.
... MoreAbbott Labs (ABT) PT Raised to $70 at Evercore ISI
July 18, 2018 12:19 PM EDTEvercore ISI raised its price target on Abbott Labs (NYSE: ABT) to $70.00 (from $66.00) while maintaining a Outperform rating.
What analyst Vijay Kumar liked in the quarter:
8% organic topline came in above ST and whisper expectationsNutrition came in above (~2% above ST) and... More